Holen Sie sich die Stockscreener-App
7.92
0.75%
-0.06
Schlusskurs vom Vortag:
$7.98
Offen:
$7.77
24-Stunden-Volumen:
748.98K
Relative Volume:
0.26
Marktkapitalisierung:
$1.07B
Einnahmen:
$24.30M
Nettoeinkommen (Verlust:
$-145.57M
KGV:
-5.9549
EPS:
-1.33
Netto-Cashflow:
$-149.17M
1W Leistung:
-5.49%
1M Leistung:
-12.29%
6M Leistung:
+428.00%
1J Leistung:
+120.00%
1-Tages-Spanne:
$7.69
$8.10
1-Wochen-Bereich:
$7.49
$8.74
52-Wochen-Spanne:
$1.03
$9.70
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie TNGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
7.92 | 1.07B | 24.30M | -145.57M | -149.17M | -1.33 |
|
ARGX
Argen X Se Adr
|
914.34 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.86 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
198.80 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
365.35 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.59 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Will Tango Therapeutics Inc. stock maintain dividend yieldMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Using AI based signals to follow Tango Therapeutics Inc.2025 Macro Impact & Short-Term High Return Strategies - newser.com
Does Tango Therapeutics Inc. fit your quant trading modelMarket Growth Report & Daily Market Momentum Tracking - newser.com
Long term hold vs stop loss in Tango Therapeutics Inc.July 2025 Trade Ideas & Daily Risk Controlled Trade Plans - newser.com
Why Tango Therapeutics Inc. is moving today2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Can Tango Therapeutics Inc. stock outperform in 2025 bull marketWeekly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
How Tango Therapeutics Inc. stock performs in rising dollar environment2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Short interest data insights for Tango Therapeutics Inc.July 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Why Tango Therapeutics Inc. stock is trending among retail tradersWeekly Market Outlook & Daily Volume Surge Trade Alerts - newser.com
Will Tango Therapeutics Inc. stock attract ESG investorsMarket Rally & Daily Profit Maximizing Trade Tips - newser.com
Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price - Yahoo Finance
How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue - Yahoo Finance
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference - The Manila Times
Wall Street Analysts Think Tango Therapeutics (TNGX) Could Surge 52.2%: Read This Before Placing a Bet - MSN
How to build a dashboard for Tango Therapeutics Inc. stockJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - newser.com
How strong is Tango Therapeutics Inc. stock balance sheet2025 Biggest Moves & Weekly Stock Performance Updates - fcp.pa.gov.br
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):